| Research & Development | |
Research |
Development |
Dr. Samuel Wiebe is conducting the world's first randomised control trial for the assessment of the impact of epilepsy surgery on health care costs. The components of this study have received praise from several international epileptologists.
Dr. Paul Derry and co-workers found that patients with significant neuroticism cope less well with the process of in-patient evaluation for intractable epilepsy.
Dr. Samuel Wiebe and co-workers are describing the Epilepsy Unit's group of patients with mesial occipital epilepsy as a syndrome within the larger context of all occipital epilepsies.
Dr. Warren Blume and co-workers are studying the findings and value of subdural electroencephalography as part of the presurgical investigation in intractable patients.
Dr. Donald Lee has correlated neuroradiological appearances in the temporal lobe with neuropathological results supporting a strictly visual analysis of MRI in temporal lobe epilepsy patients.
Dr. Ravi Menon and co-workers are commencing studies of the fMRI in temporal lobe and occipital lobe epilepsies.
Dr. Stan Leung has found a paradoxical preservation of presynaptic GABA release in the kindling model. This is due to the down regulation of GABAB presynaptic receptors in this model. This resultant preservation of inhibition in the kindling model has been viewed as an attempt by the CA1 region at self preservation. (Others have found this effect in the granule cells).
Dr. Parbeen Pathak is exploring the relationship of epileptogenesis to epileptogenic lesions. Part of this involves examining after-discharge thresholds surrounding the epileptogenic lesion (Epilepsia (1997) 38 (abstract)).
This has been established with Drs. J.P. Cain, S. Leung, C. Naus, J. Parrent, and S. Brudzynski.
Other projects at early stages include: analysis of surgical outcome in patients with normal pathology by Drs. G.R. Ganapathy and W.T. Blume.
Dr. Ramesh Sahjpaul is conducting a double blind placebo controlled randomized trial in patients with medically intractable epilepsy. If Decadron is found to reduce peri-operative morbidity an identical study will be conducted with patients undergoing craniotomy.
Drs. C. Kubu and R. Sahjpaul have developed an extensive intraoperative speech testing paradigm to assist in dominant hemisphere resections and to further their understanding of cortical language localization to be implemented in January 1998.
Our tubular subdural electrodes are made of 100% biocompatible materials except for parts that are not implanted. Medical grade Silastic tubing is injected and sealed with Xray opaque Silastic elastomer. Contacts are made of 316 stainless steel rings. The signal is taken away from the contacts by means of 316 teflon coated annealed stainless steel wires.A concentric polyethylene tubing within the silastic structure provide means to insert a removable stainless steel guide wire, achieving dual flexibility for patient comfort. The electrode can accommodate up to seven contacts.
We also produce a double sided paddle electrode. The materials used are the same as the tubular electrodes but a completely different structural design.Seven flat contacts are incorporated into each side of the electrode. The two sides are completely insulated from each other. This electrode is commonly used in our department to record ECOG from homologous mesial surfaces of each hemispheres.The paddle electrodes come in two different shapes: a slightly curved or a straight design.
We also manufacture grids with varying contact numbers. We have three types of grids. A standard flat shaped grid, a 3-D cup shaped grid to eliminate buckling at the edges in case of large contact numbers. The third type of grid does not contain spot welded stainless steel contacts as the other ones, but only looped stainless steel wires which act as contacts. The distance between contacts is usually lomm in all types of grids. Stimulation through the contacts is also possible.
Our depth electrodes are very similar in structure and shape to the tubular subdural electrodes. However, the tip consist of a stainless steel hollow "bullet", which is internally connected to a stainless steel tubing, which terminates in a Luer-lock connector. The system gives high rigidity and ability to inject dyes for marking the tip of the electrode. The depth electrode usually contains 4 contacts spaced lomm apart. We have a new depth electrode under development which is much thinner in diameter, have dual rigidity due to a guide wire and can be left in for chronic recordings of ECOG. Contact numbers can be up to 12 with varying spacing between O.lmm to lomm.
All of our electrodes come with the appropriate cables. These custom made cables have very high flexibility for patient comfort and safety. Since we are a small operation, we can custom make electrodes to patient and surgeons needs within our means. In most cases of electrodes we can vary contact spacings, electrode shapes and if the need arises , the materials the electrode is made oL The flexibility of tubular electrodes can be changed to suit the surgeons needs. Our new depth electrode under development will be stereotaxically implantable, dye markable and since it contains a concentric tubing within, tissue fluids can be withdrawn though it.
Go To TOP  
We provide digital EEG recording and review systems at both hospital sites
in order to transmit, read and report on patient EEG. LHSC has a computerized
8 bed Epilepsy unit recording digital EEG 24 hours a day , 7 days a week.
EEGs are reviewed on other PC stations within the department's local area
high speed network connecting our 2 hospital sites.
All this digital normative and epileptic EEG data allows us a great opportunity to analise and study EEG automatically. We continue to develop new techniques to facilitate recording, recognition and analysis. Some of the areas of interest are
| Services | Support & Information | ||||||
| EEG Services | Epilepsy Unit | CNS Dept | Staff | R&D | Epilepsy | Events & Announcements | Email us |
| Return to Programs and Services | Questions? Comments? Contact Cathy Johnson |
| |
| Copyright ©1996-2005 London Health Sciences Centre. Please read our disclaimer | |